Usana Health Sciences Shares Gain on 2Q Sales Bump

Dow Jones

2025/07/23

By Katherine Hamilton

Usana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter.

The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year.

Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents.

Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before.

The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August.

Usana reiterated its full-year outlook.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

July 22, 2025 18:21 ET (22:21 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2553267126"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553267126\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553267126?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553267126","market":"sg","top_or_hot":-1,"title":"Usana Health Sciences Shares Gain on 2Q Sales Bump","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/USNA\">Usana Health Sciences</a> shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n</p>\n<p>\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n</p>\n<p>\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n</p>\n<p>\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n</p>\n<p>\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n</p>\n<p>\n  Usana reiterated its full-year outlook. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2025 18:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Usana Health Sciences Shares Gain on 2Q Sales Bump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUsana Health Sciences Shares Gain on 2Q Sales Bump\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-07-23 06:21</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine <a href=\"https://laohu8.com/S/HBK\">Hamilton</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/USNA\">Usana Health Sciences</a> shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n</p>\n<p>\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n</p>\n<p>\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n</p>\n<p>\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n</p>\n<p>\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n</p>\n<p>\n  Usana reiterated its full-year outlook. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2025 18:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"優莎娜","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2553267126","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553267126","pubTimestamp":1753222860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Usana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter.The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year.Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents.Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before.The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"Usana Health Sciences股价因第二季度销售额增长而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":1},"content_text":"By Katherine Hamilton\n\n\nUsana Health Sciences shares rose after the company posted a jump in revenue and adjusted earnings in its second quarter. \n\n\n  The stock climbed 16% to $36.50 in after-hours trading Tuesday. At the close, shares were down 12% this year. \n\n\n  Revenue rose 11% to $236 million. Adjusted earnings per share rose to 74 cents from 54 cents. \n\n\n  Profit was $9.7 million, or 52 cents a share, compared with $10.4 million, or 54 cents a share, the year before. \n\n\n  The maker of nutritional and weight-management products has been pushing forward on a commercial strategy for its direct sales business. The company said during the quarter it would enhance incentive offerings, and plans to disclose further steps in August. \n\n\n  Usana reiterated its full-year outlook. \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 22, 2025 18:21 ET (22:21 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}